Innovative Mobility Solutions Cionic's lead product, the Neural Sleeve 2, is an FDA-cleared advanced wearable neurotechnology that enables functional muscle activation and spasm relaxation, positioning it as a cutting-edge solution for mobility impairments in patients with neurological conditions.

Recognition and Market Credibility Multiple awards such as the TIME Best Inventions 2025 and the Edison Gold Award highlight Cionic's innovative design and industry leadership, enhancing its attractiveness to healthcare providers seeking reputable and proven technological solutions.

Strategic Partnerships Partnerships with notable entities like the National MS Society and clinical collaborations with UCHealth and other leading rehabilitation centers position Cionic to expand its clinical footprint and build trust among potential institutional clients.

Technological Innovation Utilizing adaptive AI and connected care technologies, Cionic offers a scalable and future-proof platform that can appeal to healthcare systems investing in digital therapeutic solutions for diverse mobility disorders.

Growth and Funding With recent funding of $12 million and a revenue range of $10 million to $25 million, Cionic is positioned to capitalize on expanding its market presence, offering opportunities for sales expansion within biotechnology and healthcare sectors specializing in neurorehabilitation.